🇺🇸 FDA
Pipeline program

Golexanolone Placebo Capsules, oral capsules, soft, GR3027 10 mg

UCAB-CT-05

Phase 2 small_molecule active

Quick answer

Golexanolone Placebo Capsules, oral capsules, soft, GR3027 10 mg for Primary biliary cholangitis (PBC) is a Phase 2 program (small_molecule) at COGNITION THERAPEUTICS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
COGNITION THERAPEUTICS INC
Indication
Primary biliary cholangitis (PBC)
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials